Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alessandro Cozzi Lepri

Showing results (171-180 of 227) with videos related to

Pageof 23
Sort By:
International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases|March 15, 2025
Effectiveness of dolutegravir-based vs boosted darunavir-based first-line 3-drug regimens in people with HIV with advanced disease: A trial emulationRoberta Gagliardini, Andrea Giacomelli, Cristina Mussini, et al.
Thrombosis Research|December 4, 2014
Mild induced hypothermia: effects on sepsis-related coagulopathy--results from a randomized controlled trialMaria E Johansen, Jens-Ulrik Jensen, Morten H Bestle, et al.
Eclinicalmedicine|July 31, 2025
Risk of clinical events in virologically suppressed people with HIV switching to a two-drug regimen vs. remaining on a three-drug regimen: a target trial emulationCristina Mussini, Andrea Giacomelli, Eugenia Quiros-Roldan, et al.
Seminars in Thrombosis and Hemostasis|January 16, 2015
Profound endothelial damage predicts impending organ failure and death in sepsisMaria E Johansen, Pär I Johansson, Sisse R Ostrowski, et al.
Scientific Reports|June 1, 2021
Prophylactic heparin and risk of orotracheal intubation or death in patients with mild or moderate COVID-19 pneumoniaAlessandra Vergori, Patrizia Lorenzini, Alessandro Cozzi-Lepri, et al.
AIDS (London, England)|February 19, 2005
CD4 cell-monitored treatment interruption in patients with a CD4 cell count > 500 x 106 cells/lCristina Mussini, Andrea Bedini, Vanni Borghi, et al.
Antiviral Therapy|June 20, 2017
The association between detected drug resistance mutations and CD4<sup>+</sup> T-cell decline in HIV-positive individuals maintained on a failing treatment regimenAnna Schultze, Roger Paredes, Caroline Sabin, et al.
Journal of Medical Virology|June 12, 2023
Effect of tecovirimat on healing time and viral clearance by emulation of a target trial in patients hospitalized for mpoxValentina Mazzotta, Alessandro Cozzi-Lepri, Simone Lanini, et al.
Medicine|October 18, 2016
Long-term effectiveness of unboosted atazanavir plus abacavir/lamivudine in subjects with virological suppression: A prospective cohort studyJosep M Llibre, Alessandro Cozzi-Lepri, Court Pedersen, et al.
International Journal of Antimicrobial Agents|November 17, 2025
Impact of DNA-stored mutations on virological response in virologically suppressed PWH in the switch to modern regimensFrancesca Lombardi, Elio Gentilini Cacciola, Federica Carli, et al.
Pageof 23

Showing results (171-180 of 227) with videos related to

Sort By:
Pageof 23
International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases|March 15, 2025
Effectiveness of dolutegravir-based vs boosted darunavir-based first-line 3-drug regimens in people with HIV with advanced disease: A trial emulationRoberta Gagliardini, Andrea Giacomelli, Cristina Mussini, et al.
Thrombosis Research|December 4, 2014
Mild induced hypothermia: effects on sepsis-related coagulopathy--results from a randomized controlled trialMaria E Johansen, Jens-Ulrik Jensen, Morten H Bestle, et al.
Eclinicalmedicine|July 31, 2025
Risk of clinical events in virologically suppressed people with HIV switching to a two-drug regimen vs. remaining on a three-drug regimen: a target trial emulationCristina Mussini, Andrea Giacomelli, Eugenia Quiros-Roldan, et al.
Seminars in Thrombosis and Hemostasis|January 16, 2015
Profound endothelial damage predicts impending organ failure and death in sepsisMaria E Johansen, Pär I Johansson, Sisse R Ostrowski, et al.
Scientific Reports|June 1, 2021
Prophylactic heparin and risk of orotracheal intubation or death in patients with mild or moderate COVID-19 pneumoniaAlessandra Vergori, Patrizia Lorenzini, Alessandro Cozzi-Lepri, et al.
AIDS (London, England)|February 19, 2005
CD4 cell-monitored treatment interruption in patients with a CD4 cell count > 500 x 106 cells/lCristina Mussini, Andrea Bedini, Vanni Borghi, et al.
Antiviral Therapy|June 20, 2017
The association between detected drug resistance mutations and CD4<sup>+</sup> T-cell decline in HIV-positive individuals maintained on a failing treatment regimenAnna Schultze, Roger Paredes, Caroline Sabin, et al.
Journal of Medical Virology|June 12, 2023
Effect of tecovirimat on healing time and viral clearance by emulation of a target trial in patients hospitalized for mpoxValentina Mazzotta, Alessandro Cozzi-Lepri, Simone Lanini, et al.
Medicine|October 18, 2016
Long-term effectiveness of unboosted atazanavir plus abacavir/lamivudine in subjects with virological suppression: A prospective cohort studyJosep M Llibre, Alessandro Cozzi-Lepri, Court Pedersen, et al.
International Journal of Antimicrobial Agents|November 17, 2025
Impact of DNA-stored mutations on virological response in virologically suppressed PWH in the switch to modern regimensFrancesca Lombardi, Elio Gentilini Cacciola, Federica Carli, et al.
Pageof 23